0001437749-25-010359.txt : 20250401 0001437749-25-010359.hdr.sgml : 20250401 20250401073011 ACCESSION NUMBER: 0001437749-25-010359 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250401 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250401 DATE AS OF CHANGE: 20250401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ULTRALIFE CORP CENTRAL INDEX KEY: 0000875657 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing EIN: 161387013 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20852 FILM NUMBER: 25796583 BUSINESS ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 BUSINESS PHONE: 3153327100 MAIL ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 FORMER COMPANY: FORMER CONFORMED NAME: ULTRALIFE BATTERIES INC DATE OF NAME CHANGE: 19940224 8-K 1 ulbi20250331_8k.htm FORM 8-K ulbi20250331_8k.htm
false 0000875657 0000875657 2025-04-01 2025-04-01
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
April 1, 2025
Date of Report (Date of Earliest Event Reported)
 
 
ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
000-20852
16-1387013
(State of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
2000 Technology Parkway, Newark, New York 14513
(Address of principal executive offices) (Zip Code)
 
(315) 332-7100
(Registrant’s telephone number, including area code)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, $0.10 par value per share   ULBI   NASDAQ Stock Market
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 2.02 Results of Operations and Financial Condition
 
On April 1, 2025, Ultralife Corporation issued a press release regarding the financial results for its fourth quarter and full year ended December 31, 2024. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.
 
 
Item 9.01 Financial Statements, Pro Forma Financials and Exhibits
 
(d) Exhibits.
 
Exhibit
Number
  
Exhibit Description
  
99.1
    
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document)
  
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: April 1, 2025
  
ULTRALIFE CORPORATION
     
     
 
By:
/s/ Philip A. Fain
   
Philip A. Fain
   
Chief Financial Officer and Treasurer
     
     
 
 
 
 EX-99.1 2 ex_797283.htm EXHIBIT 99.1 ex_797283.htm

Exhibit 99.1

ul.jpg

 

Ultralife Corporation Reports Fourth Quarter Results

Acquisition of Electrochem Completed and Integration Has Commenced

 

 

NEWARK, N.Y. – April 1, 2025 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the fourth quarter and full year ended December 31, 2024 as follows:

 

Fourth Quarter:

 

 

●

Sales of $43.9 million compared to $44.5 million for the 2023 fourth quarter, including a 11.7% increase in Battery & Energy Products sales and a 55.1% decrease in Communications Systems sales
 

●

Gross profit of $10.6 million, or 24.2% of revenue, compared to $11.4 million, or 25.6% of revenue, for the 2023 fourth quarter
 

●

Operating income of $1.5 million, including one-time costs and GAAP adjustments of $1.1 million directly related to the acquisition of Electrochem Solutions, Inc. (“Electrochem”) on October 31, 2024, compared to $3.6 million for the 2023 fourth quarter
 

●

GAAP EPS of $0.01 compared to $0.17 for the 2023 fourth quarter
 

●

Adjusted EBITDA of $3.9 compared to $4.8 million for the 2023 fourth quarter
 

●

Backlog and high confidence orders of $102.2 million exiting 2024 compared to $78.0 exiting the third quarter

 

Fiscal Year 2024:

 

 

●

Sales of $164.5 million represent a 3.7% year-over-year increase; essentially flat with 2023 when excluding Electrochem
 

●

Operating income of $10.0 million including one-time costs and GAAP adjustments of $1.4 million directly related to the acquisition of Electrochem on October 31, 2024, versus $9.5 million for 2023
 

●

GAAP EPS of $0.38 compared to $0.44 for 2023 which included approximately $0.08 for recognition of the ERC filed under the Coronavirus Aid, Relief and Economic Act
 

●

Adjusted EBITDA of $16.5 million compared to $15.7 million for 2023

 

“For the fourth quarter the contribution of Electrochem compensated for delays in the timing of expected larger orders for our Communications Systems segment and customer requests to push orders into 2025 for our Battery & Energy Products segment. These fulfillment delays illustrate how fluctuations in order timing can impact our financial results on a short-term basis even as demand for our products remains strong. In addition, after acquiring Electrochem on October 31st, we began implementing our integration playbook commencing the necessary groundwork to realize the benefits of our investment,” said Mike Manna, President and Chief Executive Officer. 

 

“We entered 2025 with a healthy backlog and a schedule of new products to launch representing a broadened opportunity set in high-growth markets that position us to more fully realize the operating leverage of our business model through scale, and a strengthened sales and marketing leadership team to expedite organic growth and further leverage our global brand and resources. We are also on track to complete the acquisition integration and realize resulting manufacturing cost efficiencies and U.S.-based vertical integration savings. As a result, we are confident in our ability to deliver profitable growth and incremental cash flow enabling us to reduce debt and support strategic capital expenditures,” concluded Mr. Manna.

 

 
 

 

Fourth Quarter 2024 Financial Results

 

Revenue was $43.9 million, including $6.1 million relating to our acquisition of Electrochem, compared to revenue of $44.5 million for the fourth quarter of 2023. Battery & Energy Products sales increased 11.7% to $39.9 million compared to $35.7 million last year reflecting the inclusion of Electrochem. Organic sales for this segment declined 5.3% as a 48.1% increase in government/defenses sales and a 1.6% increase in oil & gas market sales were offset by a 47.2% decrease in medical battery sales and a 4.4% decline in other industrial market sales. Communications Systems sales decreased by 55.1% to $4.0 million compared to $8.8 million for the same period last year, primarily attributable to shipments in the prior year of vehicle-amplifier adaptors to a global defense contractor for the U.S. Army and of integrated systems of amplifiers and radio vehicle mounts to a major international defense contractor. Our total backlog and high confidence orders exiting the fourth quarter was $102.2 million compared to $78.0 million reported for the third quarter.

 

Gross profit was $10.6 million, or 24.2% of revenue, compared to $11.4 million, or 25.6% of revenue, for the same quarter a year ago. Battery & Energy Products gross margin was 23.4%, compared to 25.2% last year, primarily due to product mix and lower factory cost absorption. Communications Systems gross margin was 31.9% compared to 27.2% last year, primarily due to product mix and price realization despite lower factory volume.

 

Operating expenses were $9.1 million, compared to $7.8 million for the 2023 fourth quarter, reflecting $1.8 million for the inclusion of Electrochem and the one-time costs associated with the acquisition. Operating expenses were 20.8% of revenue compared to 17.4% of revenue for the year-earlier period.

 

Operating income was $1.5 million compared to $3.6 million last year. Driven by the 55.1% decline in Communications Systems sales and one-time acquisition costs, operating margin decreased to 3.4% compared to 8.2% last year.

 

Net income attributable to Ultralife Corporation was $0.2 million or $0.01 per diluted share on a GAAP basis, compared to $2.9 million or $0.17 per diluted share for the fourth quarter of 2023. Adjusted EPS was also $0.01 on a diluted basis for the fourth quarter of 2024, compared to $0.18 for the 2023 period. Adjusted EPS excludes the provision for deferred taxes which primarily represents non-cash charges for U.S. taxes which we expect will be fully offset by net operating loss carryforwards and other tax credits for the foreseeable future.

 

Adjusted EBITDA, defined as EBITDA including non-cash, stock-based compensation expense and one-time acquisition costs and non-cash purchase accounting adjustments, was $3.9 million for the fourth quarter of 2024, or 8.9% of sales, compared to $4.8 million, or 10.7% of sales, for the year-earlier period.

 

See the “Non-GAAP Financial Measures” section of this release for a reconciliation of adjusted EPS to EPS and adjusted EBITDA to net income attributable to Ultralife Corporation.

 

 
 

 

About Ultralife Corporation

 

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government/defense and commercial customers across the globe.

 

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

 

 

Conference Call Information

 

Ultralife will hold its fourth quarter earnings conference call on today at 8:30 AM ET.

 

To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call: https://register-conf.media-server.com/register/BI1a1f31c093654241b376ab0dfc2c088b. This will eliminate the need to speak with an operator. Once registered, dial-in information will be provided along with a personal identification number. Should you register early and misplace your details, you can simply click back on this same link at any time to register and view this information again. A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

 

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include uncertain global economic conditions, reductions in revenues from key customers, delays or reductions in U.S. and foreign military spending, acceptance of our new products on a global basis, and disruptions or delays in our supply of raw materials and components due to business conditions, global conflicts, weather or other factors not under our control. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

 

 
 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

(Unaudited)

 

ASSETS

 

   

December 31,

2024

    

December 31,

2023

  
Current Assets:                
Cash   $ 6,854     $ 10,278  
Trade Accounts Receivable, Net     29,370       31,761  
Inventories, Net     51,363       42,215  
Prepaid Expenses and Other Current Assets     9,573       5,949  
Total Current Assets     97,160       90,203  
                 
Property, Plant and Equipment, Net     40,485       21,117  
Goodwill     45,006       37,571  
Other Intangible Assets, Net     24,557       15,107  
Deferred Income Taxes, Net     8,413       10,567  
Other Non-Current Assets     4,830       3,711  
                 
Total Assets   $ 220,451     $ 178,276  

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

Current Liabilities:                
Accounts Payable   $ 14,160     $ 11,336  
Current Portion of Long-Term Debt     2,750       2,000  

Accrued Compensation and Related Benefits

     2,911       3,115  
Accrued Expenses and Other Current Liabilities     9,470       7,279  
Total Current Liabilities     29,291       23,730  
Long-Term Debt, Net     51,502       23,624  
Deferred Income Taxes     1,443       1,714  
Other Non-Current Liabilities     4,028       3,781  
Total Liabilities     86,264       52,849  
                 
Shareholders' Equity:                
Common Stock     2,107       2,078  
Capital in Excess of Par Value     191,828       189,160  
Accumulated Deficit     (34,442 )     (40,754 )
Accumulated Other Comprehensive Loss     (4,006 )     (3,660 )
Treasury Stock     (21,492 )     (21,492 )
Total Ultralife Corporation Equity     133,995       125,332  
Non-Controlling Interest     192       95  
Total Shareholders’ Equity     134,187       125,427  
                 
Total Liabilities and Shareholders' Equity   $ 220,451     $ 178,276  

 

 
 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands Except Per Share Amounts)

(Unaudited)

 

    Three-Month Period Ended     Year Ended  
   

December 31,

    

December 31,

    

December 31,

    

December 31,

  
    2024     2023     2024     2023  
Revenues:                                
Battery & Energy Products   $ 39,880     $ 35,703     $ 144,081     $ 129,953  
Communications Systems     3,972       8,845       20,375       28,691  
Total Revenues     43,852       44,548       164,456       158,644  
                                 
Cost of Products Sold:                                
Battery & Energy Products     30,549       26,711       107,764       99,178  
Communications Systems     2,704       6,435       14,378       20,266  
Total Cost of Products Sold     33,253       33,146       122,142       119,444  
                                 
Gross Profit     10,599       11,402       42,314       39,200  
                                 
Operating Expenses:                                
Research and Development     2,415       1,852       8,268       7,531  
Selling, General and Administrative     6,710       5,901       24,081       22,194  
Total Operating Expenses     9,125       7,753       32,349       29,725  
                                 
Operating Income     1,474       3,649       9,965       9,475  
                                 
Other Expense     979       536       1,664       358  
Income Before Income Taxes     495       3,113       8,301       9,117  
                                 
Income Tax Provision     262       263       1,892       1,951  
                                 
Net Income     233       2,850       6,409       7,166  
                                 
Net Income (Loss) Attributable to Non-Controlling Interest     39       (23 )     97       (31 )
                                 
Net Income Attributable to Ultralife Corporation   $ 194     $ 2,873     $ 6,312     $ 7,197  
                                 
Net Income Per Share Attributable to Ultralife Common Shareholders – Basic   $ .01     $ .18     $ .38     $ .44  
                                 
Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted   $ .01     $ .17     $ .38     $ .44  
                                 
Weighted Average Shares Outstanding – Basic     16,629       16,338       16,555       16,214  
                                 
Weighted Average Shares Outstanding – Diluted     16,762       16,479       16,767       16,226  

 

 
 

 

Non-GAAP Financial Measures

 

 

Adjusted EBITDA

 

In evaluating our business, we consider and use adjusted EBITDA, a non-GAAP financial measure, as a supplemental measure of our operating performance in addition to U.S. Generally Accepted Accounting Principles (“GAAP”) financial measures. We define adjusted EBITDA as net income attributable to Ultralife Corporation before net interest expense, provision for income taxes, depreciation and amortization, and stock-based compensation expense, plus/minus expense/income that we do not consider reflective of our ongoing continuing operations. We reconcile adjusted EBITDA to net income attributable to Ultralife Corporation, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EBITDA as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EBITDA to net income attributable to Ultralife Corporation.

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EBITDA

(Dollars in Thousands)

(Unaudited)

 

   

Three-Month Period Ended

    

Year Ended

  
   

December 31, 2024

    

December 31, 2023

    

December 31, 2024

    

December 31, 2023

  
                                 

Net Income Attributable to Ultralife Corporation

   $ 194     $ 2,873     $ 6,312     $ 7,197  

Adjustments:

                                

Interest Expense, Net

     829       566       1,940       2,016  

Income Tax Provision

     262       263       1,892       1,951  

Depreciation Expense

     831       740       3,125       3,022  

Amortization Expense

     348       226       1,032       889  

Stock-Based Compensation Expense

     208       104       698       528  

Cyber-Insurance Policy Deductible

     -       -       -       100  

Non-Recurring Acquisition Costs

     1,111       -       1,361       -  

Non-Cash Purchase Accounting Adjustment

     120       -       120       -  

Adjusted EBITDA

   $ 3,903     $ 4,772     $ 16,480     $ 15,703  

 

 
 

 

Adjusted Earnings Per Share

 

In evaluating our business, we consider and use adjusted EPS, a non-GAAP financial measure, as a supplemental measure of our business performance. We define adjusted EPS as net income attributable to Ultralife Corporation excluding the provision (benefit) for deferred income taxes divided by our weighted average shares outstanding on both a basic and diluted basis. We believe that this information is useful in providing period-to-period comparisons of our results by reflecting the portion of our tax provision that we expect will be predominantly offset by our U.S. net operating loss carryforwards and other tax credits for the foreseeable future. We reconcile adjusted EPS to EPS, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EPS as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EPS to EPS and net income attributable to Ultralife Corporation.

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EPS

(In Thousands Except Per Share Amounts)

(Unaudited)
   

Three-Month Period Ended

  
   

December 31, 2024

    

December 31, 2023

  
   

Amount

    

Per Basic Share

    

Per Diluted Share

    

Amount

    

Per Basic Share

    

Per Diluted Share

  

Net Income Attributable to Ultralife Corporation

   $ 194     $ .01     $ .01     $ 2,873     $ .18     $ .17  

Deferred Tax Provision (Benefit)

     (63 )     -       -       56       -       .01  

Adjusted Net Income

   $ 131     $ .01     $ .01     $ 2,929     $ .18     $ .18  
                                                 

Weighted Average Shares Outstanding

             16,629       16,762               16,338       16,479  

 

   

Year Ended

  
   

December 31, 2024

    

December 31, 2023

  
   

Amount

    

Per Basic Share

    

Per Diluted Share

    

Amount

    

Per Basic Share

    

Per Diluted Share

  

Net Income Attributable to Ultralife Corporation

   $ 6,312     $ .38     $ .38     $ 7,197     $ .44     $ .44  

Deferred Tax Provision

     1,232       .08       .07       1,301       .08       .08  

Adjusted Net Income

   $ 7,544     $ .46     $ .45     $ 8,498     $ .52     $ .52  
                                                 

Weighted Average Shares Outstanding

             16,555       16,767               16,214       16,226  

 

 
 

 

Company Contact:

Ultralife Corporation

Philip A. Fain

(315) 210-6110

pfain@ulbi.com

 

Investor Relations Contact:

LHA

Jody Burfening

(212) 838-3777

jburfening@lhai.com

 

 
 EX-101.SCH 3 ulbi-20250401.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 ulbi-20250401_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 ulbi-20250401_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 ulbi-20250401_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 ul.jpg begin 644 ul.jpg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htm IDEA: XBRL DOCUMENT v3.25.1
Document And Entity Information
Apr. 01, 2025
Document Information [Line Items]  
Entity, Registrant Name ULTRALIFE CORPORATION
Document, Type 8-K
Document, Period End Date Apr. 01, 2025
Entity, Incorporation, State or Country Code DE
Entity, File Number 000-20852
Entity, Tax Identification Number 16-1387013
Entity, Address, Address Line One 2000 Technology Parkway
Entity, Address, City or Town Newark
Entity, Address, State or Province NY
Entity, Address, Postal Zip Code 14513
City Area Code 315
Local Phone Number 332-7100
Title of 12(b) Security Common Stock
Trading Symbol ULBI
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000875657
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.1 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.ulbi.com/20250401/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports ulbi-20250401.xsd ulbi-20250401_def.xml ulbi-20250401_lab.xml ulbi-20250401_pre.xml ulbi20250331_8k.htm http://xbrl.sec.gov/dei/2024 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ulbi20250331_8k.htm": { "nsprefix": "ulbi", "nsuri": "http://www.ulbi.com/20250401", "dts": { "schema": { "local": [ "ulbi-20250401.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/currency/2024/currency-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-8k-sub-2024.xsd", "https://xbrl.sec.gov/cyd/2024/cyd-cr-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/exch/2024/exch-2024.xsd", "https://xbrl.sec.gov/sic/2024/sic-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "ulbi-20250401_def.xml" ] }, "labelLink": { "local": [ "ulbi-20250401_lab.xml" ] }, "presentationLink": { "local": [ "ulbi-20250401_pre.xml" ] }, "inline": { "local": [ "ulbi20250331_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 36, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://www.ulbi.com/20250401/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20258K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ulbi20250331_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20258K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "div", "td", "tr", "tbody", "table", "body", "html" ], "reportCount": 1, "baseRef": "ulbi20250331_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "cyd_MaterialCybersecurityIncidentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentAbstract", "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Abstract]" } } }, "auth_ref": [ "r6", "r7" ] }, "cyd_MaterialCybersecurityIncidentAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentAxis", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Axis]" } } }, "auth_ref": [ "r6", "r7" ] }, "cyd_MaterialCybersecurityIncidentDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentDomain", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Domain]" } } }, "auth_ref": [ "r6", "r7" ] }, "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]" } } }, "auth_ref": [ "r6", "r8" ] }, "cyd_MaterialCybersecurityIncidentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentLineItems", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Line Items]" } } }, "auth_ref": [ "r6", "r9" ] }, "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]" } } }, "auth_ref": [ "r6", "r9" ] }, "cyd_MaterialCybersecurityIncidentNatureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentNatureTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Nature [Text Block]" } } }, "auth_ref": [ "r6", "r9" ] }, "cyd_MaterialCybersecurityIncidentScopeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentScopeTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Scope [Text Block]" } } }, "auth_ref": [ "r6", "r9" ] }, "cyd_MaterialCybersecurityIncidentTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentTable", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident [Table]" } } }, "auth_ref": [ "r6", "r7" ] }, "cyd_MaterialCybersecurityIncidentTimingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2024", "localname": "MaterialCybersecurityIncidentTimingTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" ], "lang": { "en-us": { "role": { "label": "Material Cybersecurity Incident Timing [Text Block]" } } }, "auth_ref": [ "r6", "r9" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.ulbi.com/20250401/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r10" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 6-K", "Section": "General Instruction", "Subsection": "B" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "Instruction", "Paragraph": "2" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Section": "1.05", "Subsection": "a" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001437749-25-010359-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-25-010359-xbrl.zip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end XML 18 ulbi20250331_8k_htm.xml IDEA: XBRL DOCUMENT 0000875657 2025-04-01 2025-04-01 false 0000875657 8-K 2025-04-01 ULTRALIFE CORPORATION DE 000-20852 16-1387013 2000 Technology Parkway Newark NY 14513 315 332-7100 Common Stock ULBI NASDAQ false false false false false